-

Kate Jeffrey, PhD – Moderna USA

16/12/2024 2:00 pm - 16/12/2024 3:00 pm
Location
Davis Auditorium

WEHI Director’s Seminar hosted by Professors Ken Smith & Vihandha Wickramasinghe

 

Kate Jeffrey, PhD

Vice President and Global Head of Immune Therapeutics and Genomic Sciences at Moderna in Cambridge, Massachusetts, USA

 

mRNA: A new era in vaccines and therapeutics

Davis Auditorium

Join via TEAMS

Including Q&A session

 

Kate defines strategy and drives discovery and development of therapeutics covering autoimmunity, inflammation, hematology and rare disease using Moderna’s proprietary mRNA technology and modalities. Prior to joining Moderna, Kate had a highly successful academic career at Harvard Medical School and Massachusetts General Hospital where she was an Associate Professor of Medicine, a John Lawrence Research Scholar, a faculty member of Harvard Immunology, Harvard Virology, MIT Microbiome Centre for Microbiome Informatics and Therapeutics and a member of the Broad Institute of Harvard and MIT. Kate performed her Ph.D. in Immunology at the Garvan Institute of Medical Research in Sydney, Australia and her postdoctoral research at The Rockefeller University in New York City under a CJ Martin National Health and Medical Research Council (NHMRC) fellowship. Kate is the recipient of multiple awards for her work in immunology and epigenetics including the Rockefeller Women in Science Award, Kenneth Rainin Foundation Innovator Award, Claflin Distinguished Scholar Award and MGH Research Scholar Award. Kate was also the co-founder of the Imagine Science Film Festival in New York and gave a TEDx talk.

 

 

 

All Welcome!

Support us

Together we can create a brighter future

Your support will help WEHI’s researchers make discoveries and find treatments to ensure healthier, longer lives for you and your loved ones.

Sign up to our quarterly newsletter Illuminate

Find out about recent discoveries, community supporters and more.

Illuminate Summer 2024
View the current issue